Bafazol IC – the means influencing nervous system. Psycholeptic means.
Medicine is shown toto use by the adult for treatment of disturbing states: generalized anxiety disorders, a neurasthenia, adaptation disorders, to patients with various somatopathies (bronchial asthma, a syndrome of the angry intestines, a system lupus erythematosus, coronary heart disease, arterial hypertension, and other diseases
apply Medicine to treatment of the sleep disorders connected with alarm; neurocirculatory dystonia, a premenstrual syndrome, an alcoholic abstinence syndrome for simplification of a withdrawal at refusal of smoking.
Structure
- active ingredient: fabomotizol;
- 1 tablet contains fabomotizol dihydrochloride of 10 mg;
- other components: potato starch, cellulose microcrystalline, StarLac® (lactoses monohydrate, starch corn), talc, silicon dioxide colloidal anhydrous, magnesium stearate.
Contraindication
Individual intolerance of any components of medicine. Intolerance of a galactose, deficiency of lactase or sprue of glucose galactose. Period of pregnancy and feeding by a breast. Children's age aged up to 18 years.
Side reactionsemergence of allergic reactions Is possible
.
it is rare – the headache which is usually passing independently and not demanding medicine cancellation.
Route of administrationto Apply
inside after a meal.
Optimum single dose makes 10 mg, a daily dose – 30 mg which should be distributed on 3 receptions within a day. Duration of a course of treatment – 2–4 weeks.
In case of need according to the recommendation of the doctor can increase a daily dose of medicine to 60 mg, and treatment duration – up to 3 months.
Feature of use
Before medicine use to patients with the established intolerance of some sugars should consult with the doctor.
Because of lactose content medicine should not be accepted to patients with rare hereditary intolerance of a galactose, deficiency of lactase or a sprue of glucose galactose.
Use during pregnancy or feeding by a breast toUse of medicine during pregnancy is contraindicated to
.
for medicine use feeding by a breast should be stopped.
toChildren
tomedicine Use is contraindicated to children up to 18 years.
Ability to influence speed of response at control of motor transport or other mechanisms
Medicine has no negative impact on ability to run motor transport and ability to carry out potentially dangerous types of activity demanding the increased concentration of attention and speed of psychomotor reactions.
OverdoseAt considerable overdose and intoxication the development of sedation and the increased drowsiness without muscle relaxation is possible
.
Treatment. As measures of emergency treatment it is necessary to apply caffeine, 20% solution to injections on 1 ml 2-3 times a day subcutaneously.
Interaction with other medicines and other types of interactions
Fabomotizol does not interact with ethanol, does not influence hypnotic effect of thiopental. Enhances anticonvulsant effect of carbamazepine. Causes strengthening of anxiolytic effect of diazepam.
Storage conditionsto Store
in original packing at a temperature not over 25 ºС. to Store
out of children's reach.
Characteristics | |
Active ingredients | Fabomotizol |
Amount of active ingredient | 10 mg |
Applicant | Interkhim |
Code of automatic telephone exchange | N05BX04 Fabomotizol |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Prescription status | Without prescription |
Primary packing | blister |
Producer | INTERKHIM ODO |
Quantity in packing | 40 tablets (2 blisters on 20 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Bafazol |
Bafazol _s tab. of 10 mg No. 40
- Product Code: 184022
- In Stock
- Ready to ship
-
$26.54